US Patent 12109196 Non-sedating dexmedetomidine treatment regimens
Patent 12109196 was granted and assigned to Bioxcel Therapeutics Inc. on October, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 16, 2024
0
Date of Patent
October 8, 2024
0
Patent Applicant
Patent Application Number
18443689
0
Patent Citations
•••
Patent Inventor Names
David Christian Hanley
0
Lavanya Rajachandran
0
Frank Yocca
0
Vasukumar Kakumanu
0
Chetan Dalpatbhai Lathia
0
Robert Risinger
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12109196 Non-sedating dexmedetomidine treatment regimens
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.